- Home
- MOH vs CAI Comparison
MOH vs CAI Comparison
Compare MOH & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOH | CAI |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.2B |
| IPO Year | 2003 | 2025 |
Fundamental Metrics
Financial Performance| Metric | MOH | CAI |
|---|---|---|
| Price | $159.80 | $27.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $205.67 | $34.43 |
| AVG Volume (30 Days) | 1.8M | ★ 2.5M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 16.24 | N/A |
| Revenue | ★ $42,842,000,000.00 | $649,062,000.00 |
| Revenue This Year | $15.34 | $77.69 |
| Revenue Next Year | $4.44 | $35.80 |
| P/E Ratio | $9.88 | ★ N/A |
| Revenue Growth | 14.11 | ★ 112.02 |
| 52 Week Low | $133.40 | $22.86 |
| 52 Week High | $359.97 | $42.50 |
Technical Indicators
Market Signals| Indicator | MOH | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 59.89 | N/A |
| Support Level | $142.28 | N/A |
| Resistance Level | $151.00 | N/A |
| Average True Range (ATR) | 4.89 | 0.00 |
| MACD | 3.08 | 0.00 |
| Stochastic Oscillator | 98.18 | 0.00 |
Price Performance
Historical ComparisonAbout MOH Molina Healthcare Inc
Molina provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in just four states—California, New York, Texas, and Washington—account for over half of its enrollees.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.